David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Donaldson
DCI
$10.7B
| $259K | ﹤0.01% |
3,739
-33,912
| -90% | -$2.28M |
|
3827
CALL
C.H. Robinson
CHRW
$16.7B
| $259K | ﹤0.01% |
2,700
-16,300
| -86% | -$1.53M |
|
3828
Stevanato
STVN
$6.08B
| $259K | ﹤0.01% |
10,600
-2,300
| -18% | -$52K |
|
3829
WisdomTree US MidCap Fund
EZM
$952M
| $259K | ﹤0.01% |
4,191
| – | – |
|
3830
CALL
Methanex
MEOH
$4.57B
| $258K | ﹤0.01% |
+7,800
| New | +$251K |
|
3831
Matrix Service
MTRX
$301M
| $258K | ﹤0.01% |
19,073
-20,960
| -52% | -$253K |
|
3832
Darling Ingredients
DAR
$9.83B
| $258K | ﹤0.01% |
+6,789
| New | +$223K |
|
3833
Leidos
LDOS
$17.4B
| $257K | ﹤0.01% |
1,632
-3,605
| -69% | -$533K |
|
|
SAFE
3834
CALL
Safehold
SAFE
$1.1B
| $257K | ﹤0.01% |
+16,500
| New | +$256K |
|
3835
CALL
Symbotic
SYM
$5.2B
| $256K | ﹤0.01% |
6,600
-6,700
| -50% | -$175K |
|
3836
Spok Holdings
SPOK
$222M
| $256K | ﹤0.01% |
+14,499
| New | +$234K |
|
|
IPCX
3837
DELISTED
Inflection Point Acquisition Corp III
IPCX
| $256K | ﹤0.01% |
+25,000
| New | +$255K |
|
3838
PUT
Cogent Communications
CCOI
$486M
| $256K | ﹤0.01% |
+5,300
| New | +$269K |
|
3839
PUT
Ameresco
AMRC
$1.11B
| $255K | ﹤0.01% |
+16,800
| New | +$220K |
|
3840
Taylor Devices
TAYD
$187M
| $255K | ﹤0.01% |
+5,877
| New | +$209K |
|
3841
AtriCure
ATRC
$2.51B
| $255K | ﹤0.01% |
7,776
-17,579
| -69% | -$571K |
|
3842
PUT
Eldorado Gold
EGO
$12.1B
| $254K | ﹤0.01% |
+12,500
| New | +$243K |
|
3843
MBIA
MBI
$250M
| $254K | ﹤0.01% |
58,542
-27,640
| -32% | -$123K |
|
|
CBL
3844
CBL Properties
CBL
$1.72B
| $253K | ﹤0.01% |
9,982
-5,506
| -36% | -$136K |
|
3845
CALL
BRC Group Holdings
RILY
$283M
| $252K | ﹤0.01% |
85,000
| – | – |
|
3846
Structure Therapeutics
GPCR
$3.49B
| $252K | ﹤0.01% |
12,165
+504
| +4% | +$11.1K |
|
3847
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$266M
| $252K | ﹤0.01% |
6,050
| – | – |
|
3848
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $250K | ﹤0.01% |
+5,913
| New | +$236K |
|
3849
Inspired Entertainment
INSE
$159M
| $250K | ﹤0.01% |
30,554
+13,722
| +82% | +$106K |
|
3850
Dimensional US Large Cap Value ETF
DFLV
$7.08B
| $250K | ﹤0.01% |
+8,045
| New | +$238K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.